Louisiana Risperdal Lawsuits Could Move Forward

Louisiana Risperdal LawsuitRisperdal, manufactured and marketed by Johnson & Johnson, is an antipsychotic medication prescribed to help treat the symptoms of bipolar mania, schizophrenia, and irritability. However, the drug has recently been linked to the development of male breasts – a condition known as gynecomastia. As a result, plaintiffs throughout the U.S. are filing lawsuits against the manufacturer, and Risperdal litigation is currently underway in Pennsylvania’s Philadelphia Court of Common Pleas.

An Order dated September 24, 2014 stated that the first three bellwether trials in the litigation have been rescheduled as follows:

  • The first trial will begin on November 3, 2014 instead of September 29, 2014
  • The second trial will begin on January 3, 2015 instead of November 3. 2014
  • The third trial will begin in February 2015

If you would like to learn more about joining the growing litigation, please contact Attorney Group for Louisiana today for a free case evaluation. We can help determine if you have a case, and we can connect you with an attorney who can further assist you.

Plaintiffs File Gynecomastia Lawsuits

According to court documents, there are more than 700 Risperdal lawsuits pending against Johnson & Johnson in the Risperdal litigation. Plaintiffs filing a Risperdal lawsuit accuse the manufacturer of failing to warn of the potential dangers of the medication, and claim that they developed male breasts during treatment.

Diabetes, Gynecomastia Among Complications

The Journal of Clinical Psychopharmacology published a study on August 6, 2014 in which researchers determined that older men taking antipsychotics such as Risperdal were 69 percent more likely to develop gynecomastia than their drug-free counterparts. According to researchers, Risperdal may increase the level of prolactin in the body – the hormone responsible for breast growth and lactation in women.

Additionally, two studies have found that Risperdal may also increase a child’s risk of developing type 2 diabetes. Researchers in both studies, conducted in August 2013 and September 2014, concluded that children taking Risperdal may be three times more likely to develop diabetes than others of the same age who refrained from using atypical antipsychotics.

Do You Believe You Have a Risperdal Lawsuit? Attorney Group for Louisiana Can Help

Have you or a loved one taken Risperdal in Louisiana and you developed gynecomastia during treatment? If so, you may have legal options. Attorney Group for Louisiana can review your case, free of charge, and help determine whether you are eligible to recover damages for your condition. If we find that you have a case, we can put you in touch with one of our affiliated attorneys in Louisiana who can file your Risperdal lawsuit on your behalf. Call today to learn more.